Detalles de la búsqueda
1.
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
Ann Rheum Dis
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423757
2.
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.
Rheumatology (Oxford)
; 63(2): 525-533, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208196
3.
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
J Rheumatol
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490668
4.
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Rheumatology (Oxford)
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934120
5.
mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Rheumatology (Oxford)
; 61(7): 3010-3022, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34791054
6.
Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis.
Mod Rheumatol
; 32(6): 1077-1085, 2022 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915579
7.
Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
Rheumatology (Oxford)
; 60(11): 5452-5462, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33693564
8.
Intracranial vessel wall lesions in patients with systematic lupus erythematosus.
J Magn Reson Imaging
; 48(5): 1237-1246, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473985
9.
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Lancet Rheumatol
; 5(10): e584-e593, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251484
10.
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study.
Arthritis Rheumatol
; 75(3): 401-410, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36122172
11.
Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Front Med (Lausanne)
; 9: 934937, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35966881
12.
Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Arthritis Res Ther
; 24(1): 86, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428323
13.
IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis.
Inflamm Regen
; 42(1): 46, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324153
14.
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study.
Arthritis Res Ther
; 24(1): 70, 2022 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35287720
15.
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study.
Lancet Rheumatol
; 4(12): e831-e841, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261391
16.
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study.
Lancet Rheumatol
; 4(12): e822-e830, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261390
17.
Involvement of lncRNA IL21-AS1 in interleukin-2 and T follicular regulatory cell activation in systemic lupus erythematosus.
Arthritis Res Ther
; 23(1): 302, 2021 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34895341
18.
Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 73(1): 132-142, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32720470
19.
Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
Front Immunol
; 11: 593103, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329581
20.
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Int J Rheum Dis
; 23(4): 549-558, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020727